ACE2 and long COVID-19: The angiotensin-converting enzyme 2 (ACE2) receptor used by SARS-CoV-2, is highly expressed in the respiratory tract and intestines, which suggests that the virus can cause long-term tissue injury and post-acute sequelae of SARS-CoV-2 infection (PASC) by compromising large mucosal surfaces (9).